| Literature DB >> 19066214 |
Tie-Jun Sten Shi1, Su-Xing Leslie Liu, Henrik Hammarberg, Masahiko Watanabe, Zhi-Qing David Xu, Tomas Hökfelt.
Abstract
Treatment of neuropathic pain is a major clinical problem. This study shows expression of phospholipase ss3 (PLCss3) in mouse and human DRG neurons, mainly in small ones and mostly with a nonpeptidergic phenotype. After spared nerve injury, the pain threshold was strongly reduced, and systemic treatment of such animals with the unselective PLC inhibitor U73122 caused a rapid and long-lasting (48-h) increase in pain threshold. Thus, inhibition of PLC may provide a way to treat neuropathic pain.Entities:
Mesh:
Substances:
Year: 2008 PMID: 19066214 PMCID: PMC2604939 DOI: 10.1073/pnas.0810899105
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205